5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.59▲ | 4.54▲ | 4.54▲ | 4.54▲ | 4.51▲ |
MA10 | 4.54▲ | 4.51▲ | 4.49▲ | 4.83▼ | 3.89▲ |
MA20 | 4.40▲ | 4.46▲ | 4.47▲ | 4.50▲ | 3.63▲ |
MA50 | 4.53▲ | 4.68▼ | 4.80▼ | 3.83▲ | 3.75▲ |
MA100 | 4.81▼ | 4.71▼ | 4.56▲ | 3.64▲ | 4.29▲ |
MA200 | 4.62▼ | 4.34▲ | 4.06▲ | 3.73▲ | 5.06▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.034▲ | 0.042▲ | 0.039▲ | -0.053▼ | 0.194▲ |
RSI | 55.372▲ | 52.864▲ | 51.620▲ | 54.306▲ | 59.070▲ |
STOCH | 91.730▲ | 84.419▲ | 83.159▲ | 36.211 | 71.692 |
WILL %R | -2.381▲ | -2.381▲ | -27.027 | -61.340 | -40.569 |
CCI | 88.148 | 100.324▲ | 75.970 | -28.804 | 100.999▲ |
CDL | $LTRN Doji Candlestick Pattern Detected | Set Alert |
Thursday, August 14, 2025 12:08 PM
Lantern Pharma (NASDAQ: LTRN) , a clinical-stage biopharma company leveraging its RADR(R) AI/ML platform for oncology drug discovery and development, ...
|
Wednesday, August 13, 2025 08:30 AM
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform the cost, ...
|
Wednesday, August 13, 2025 04:12 AM
NYSE:LRN 1 Year Share Price vs Fair Value Explore Stride's Fair Values from the Community and select yours Stride, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 4.55 | 4.69 | 4.25 | 4.57 | 72,012 |
14/08/25 | 4.52 | 4.60 | 4.00 | 4.57 | 162,383 |
13/08/25 | 4.50 | 4.8618 | 4.46 | 4.76 | 57,981 |
12/08/25 | 4.33 | 4.57 | 4.3001 | 4.45 | 90,170 |
11/08/25 | 4.94 | 4.9795 | 4.2001 | 4.33 | 207,147 |
08/08/25 | 5.10 | 5.245 | 4.85 | 4.99 | 127,264 |
07/08/25 | 5.15 | 5.2805 | 4.85 | 4.99 | 242,073 |
06/08/25 | 5.50 | 5.7441 | 5.02 | 5.14 | 270,964 |
05/08/25 | 5.60 | 5.60 | 5.03 | 5.20 | 172,140 |
04/08/25 | 5.04 | 5.50 | 4.87 | 5.32 | 407,644 |
|
|
||||
|
|
||||
|
|